Puma Biotechnology | PBYI - Market Capitalization


Puma Biotechnology reported $341.3M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Exelixis USD 14.34B 3.44B May/2026
Gilead Sciences USD 167.39B 5.6B May/2026
Incyte USD 21.73B 3B May/2026
MacroGenics USD 102M 4M Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.16B 123M May/2026
Takeda JPY 8.33T 681.01B May/2026
TG Therapeutics USD 6.48B 1.18B May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Vertex Pharmaceuticals USD 113.58B 1000K May/2026